Clinical Trial Update: GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft [Phase 4]

View source ↗

Summary

Phase 4 trial comparing GORE PROPATEN Vascular Graft with disadvantaged autologous vein graft for Peripheral Arterial Occlusive Disease was terminated; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Occlusive Disease

Drugs mentioned

• GORE PROPATEN Vascular Graft

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Peripheral Arterial Occlusive Disease | Phase 4 | Status: TERMINATED | Results posted: 2012-01-12